or Try an Advanced Search...

    ETF Components for EUDV - ProShares MSCI Europe Dividend Growers ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    DEO F 0.04 2.50
    NVS D 0.88 2.32

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Alcohol Alcoholic Drinks Animal Health Antibiotics Beer Biotechnology Blood Test Canadian Whisky Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Distilled Drinks Drink Drugs Eye Eye Care Eye Care Products
    Industries: Beverages - Wineries & Distilleries Drug Manufacturers - Major

    Recent News for ProShares MSCI Europe Dividend Growers ETF & its Holdings

    Date Stock Title
    Nov 1 NVS Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
    Nov 1 DEO TEQUILA DON JULIO ELEVATES MEXICO'S CULTURAL HERITAGE WITH BREATHTAKING DIA DE MUERTOS GLOBAL CELEBRATIONS
    Nov 1 NVS Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up
    Nov 1 NVS Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down
    Oct 31 DEO Aged to Perfection: Crown Royal Launches Iconic Reserve Offering with 12-Year Age Statement
    Oct 31 NVS REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales
    Oct 30 NVS Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
    Oct 30 DEO Ketel One Family Made Vodka Taps Patrick Schwarzenegger to Serve as First Ever "Spirit Advisor" this Holiday Season
    Oct 30 NVS Lilly's Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock Tanks
    Oct 30 NVS BioMarin Q3 Earnings & Revenues Beat Estimates, '24 Guidance Raised
    Oct 30 NVS ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
    Oct 30 NVS Novartis’ Scemblix gains FDA approval for leukaemia
    Oct 30 NVS Novartis: It's Not Too Late To Buy This Dividend Stock Now
    Oct 30 NVS Novartis Reports Strong Q3 Growth and Raises Guidance
    Oct 30 NVS Novartis AG (NVS) Q3 2024 Earnings Call Highlights: Record Cash Flow and Robust Sales Growth
    Oct 29 NVS Novartis: Strong Financials, But Market Skepticism Persists Amid Pipeline Concerns
    Oct 29 NVS Novartis wins first-line chronic myeloid leukemia indication for Scemblix
    Oct 29 NVS Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
    Oct 29 NVS Novartis Stock Dives on $800 Million Write-Down
    Oct 29 NVS Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
    The investment seeks investment results, before fees and expenses, that track the performance of the MSCI Europe Dividend Masters Index (the "index"). The fund will invest at least 80% of its total assets in component securities (i.e., securities of the index and comparable securities that have economic characteristics that are substantially identical to the economic characteristics of the securities of the index). The index, constructed and maintained by MSCI, targets companies that are currently members of the MSCI Europe Index ("MSCI Europe") and have increased dividend payments each year for at least 10 years.
    Exchange Traded Fund ETF
    Back to the Main EUDV Page...